These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 34896001)

  • 1. Distinguishing Tumor Recurrence From Radiation Necrosis in Treated Glioblastoma Using Multiparametric MRI.
    Feng A; Yuan P; Huang T; Li L; Lyu J
    Acad Radiol; 2022 Sep; 29(9):1320-1331. PubMed ID: 34896001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent glioblastoma multiforme versus radiation injury: a multiparametric 3-T MR approach.
    Di Costanzo A; Scarabino T; Trojsi F; Popolizio T; Bonavita S; de Cristofaro M; Conforti R; Cristofano A; Colonnese C; Salvolini U; Tedeschi G
    Radiol Med; 2014 Aug; 119(8):616-24. PubMed ID: 24408041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating glioblastoma from primary central nervous system lymphoma of atypical manifestation using multiparametric magnetic resonance imaging: A comparative study.
    Feng A; Li L; Huang T; Li S; He N; Huang L; Zeng M; Lyu J
    Heliyon; 2023 Apr; 9(4):e15150. PubMed ID: 37095995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinction between glioma progression and post-radiation change by combined physiologic MR imaging.
    Matsusue E; Fink JR; Rockhill JK; Ogawa T; Maravilla KR
    Neuroradiology; 2010 Apr; 52(4):297-306. PubMed ID: 19834699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined 3 Tesla MRI Biomarkers Improve the Differentiation between Benign vs Malignant Single Ring Enhancing Brain Masses.
    Salice S; Esposito R; Ciavardelli D; Delli Pizzi S; di Bastiano R; Tartaro A
    PLoS One; 2016; 11(7):e0159047. PubMed ID: 27410226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of glioblastoma multiforme from metastatic brain tumor using proton magnetic resonance spectroscopy, diffusion and perfusion metrics at 3 T.
    Tsougos I; Svolos P; Kousi E; Fountas K; Theodorou K; Fezoulidis I; Kapsalaki E
    Cancer Imaging; 2012 Oct; 12(3):423-36. PubMed ID: 23108208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging.
    Zonari P; Baraldi P; Crisi G
    Neuroradiology; 2007 Oct; 49(10):795-803. PubMed ID: 17619871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of unsupervised classification methods for brain tumor segmentation using multi-parametric MRI.
    Sauwen N; Acou M; Van Cauter S; Sima DM; Veraart J; Maes F; Himmelreich U; Achten E; Van Huffel S
    Neuroimage Clin; 2016; 12():753-764. PubMed ID: 27812502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of FDG-PET/MRI, FDG-PET/CT, and Dynamic Susceptibility Contrast Perfusion MRI in Differentiating Radiation Necrosis from Tumor Recurrence in Glioblastomas.
    Hojjati M; Badve C; Garg V; Tatsuoka C; Rogers L; Sloan A; Faulhaber P; Ros PR; Wolansky LJ
    J Neuroimaging; 2018 Jan; 28(1):118-125. PubMed ID: 28718993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of multiparametric MRI in the evaluation of treatment response in glioma patients at 3T.
    Liu J; Li C; Chen Y; Lv X; Lv Y; Zhou J; Xi S; Dou W; Qian L; Zheng H; Wu Y; Chen Z
    J Magn Reson Imaging; 2020 Apr; 51(4):1154-1161. PubMed ID: 31430008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric Analysis Combining DSC-MR Perfusion and [18F]FET-PET is Superior to a Single Parameter Approach for Differentiation of Progressive Glioma from Radiation Necrosis.
    Panholzer J; Malsiner-Walli G; Grün B; Kalev O; Sonnberger M; Pichler R
    Clin Neuroradiol; 2024 Jun; 34(2):351-360. PubMed ID: 38157019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between DTI-derived metrics and MRS metabolites in tumour regions of glioblastoma: a pilot study.
    Flores-Alvarez E; Anselmo Rios Piedra E; Cruz-Priego GA; Durand-Muñoz C; Moreno-Jimenez S; Roldan-Valadez E
    Radiol Oncol; 2020 Sep; 54(4):394-408. PubMed ID: 32990651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparametric MRI for Differentiation of Radiation Necrosis From Recurrent Tumor in Patients With Treated Glioblastoma.
    Nael K; Bauer AH; Hormigo A; Lemole M; Germano IM; Puig J; Stea B
    AJR Am J Roentgenol; 2018 Jan; 210(1):18-23. PubMed ID: 28952810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioma grading using multiparametric MRI: head-to-head comparison among dynamic susceptibility contrast, dynamic contrast-enhancement, diffusion-weighted images, and MR spectroscopy.
    Seo M; Choi Y; Soo Lee Y; Ahn KJ; Kim BS; Park JS; Jeon SS
    Eur J Radiol; 2023 Aug; 165():110888. PubMed ID: 37257338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective comparative diagnostic accuracy evaluation of dynamic contrast-enhanced (DCE) vs. dynamic susceptibility contrast (DSC) MR perfusion in differentiating tumor recurrence from radiation necrosis in treated high-grade gliomas.
    Zakhari N; Taccone MS; Torres CH; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Cron GO; Thornhill RE; McInnes MDF; Nguyen TB
    J Magn Reson Imaging; 2019 Aug; 50(2):573-582. PubMed ID: 30614146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects.
    Fink JR; Carr RB; Matsusue E; Iyer RS; Rockhill JK; Haynor DR; Maravilla KR
    J Magn Reson Imaging; 2012 Jan; 35(1):56-63. PubMed ID: 22002882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric MR Imaging of Diffusion and Perfusion in Contrast-enhancing and Nonenhancing Components in Patients with Glioblastoma.
    Boonzaier NR; Larkin TJ; Matys T; van der Hoorn A; Yan JL; Price SJ
    Radiology; 2017 Jul; 284(1):180-190. PubMed ID: 28240563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling.
    Huang J; Wang AM; Shetty A; Maitz AH; Yan D; Doyle D; Richey K; Park S; Pieper DR; Chen PY; Grills IS
    Magn Reson Imaging; 2011 Sep; 29(7):993-1001. PubMed ID: 21571478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.